MedImmune, a wholly owned subsidy of AstraZeneca, is one of the world's leading biotechnology companies. The company manufactures and markets formulations for use in immunization programs, including live virus vaccines. MedImmune is primarily focused on infection, oncology, respiratory disease and inflammation, cardiovascular/gastrointestinal disease, and neuroscience.
NAICS 325, Chemical Manufacturing
Date of Pledge: October 2010